Article
Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
Molecular pharmacology - 1 Jun 2009
Petit-Topin Isabelle, Turque Nathalie, Fagart Jérôme, Fay Michel, Ulmann André, Gainer Erin, Rafestin-Oblin Marie-Edith
Abstract excerpt
Many progestins have been developed for use in contraception, menopausal hormone therapy, and treatment of gynecological diseases. They are derived from either progesterone or testosterone, and they act by binding to the progesterone receptor (PR), a hormone-inducible transcription factor belonging to the nuclear receptor superfamily. Unlike mineralocorticoid, glucocorticoid, and androgen receptors, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
